November 13, 2023
We are pleased to invite investors and analysts to participate in our virtual event on Tuesday,
12 December 2023, highlighting Roche data presented at the 65th American Society of Hematology Annual Meeting and Exposition, from 9th to 12th December, 2023.
18:00 – 19:00 CET / 17:00 - 18:00 GMT
12:00 pm – 01:00 pm EST / 9:00 – 10:00 am PST
The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 17:00 CET on the day of the event. >click here
Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.
Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to email@example.com.
A replay of the webcast will be available via > ir.roche.com
Head of Investor Relations
Investor Relations Officer
Roche Investor Relations
Dr. Bruno Eschli
Phone: +41 61 68-75284
Dr. Sabine Borngräber
Phone: +41 61 68-88027
Dr. Birgit Masjost
Phone: +41 61 68-84814
Dr. Gerard Tobin
Phone: +41 61 68-72942
Investor Relations North America
Phone: +1 650 225 3217